SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV

People living with HIV (PLWH) are prioritised for SARS-CoV-2 vaccination due to their vulnerability to severe COVID-19. Therefore, the epidemiological surveillance of vaccination coverage and the timely identification of suboptimally vaccinated PLWH is vital. We assessed SARS-CoV-2 vaccination cover...

Descripción completa

Detalles Bibliográficos
Autores: Nomah, DK; Llibre, JM; Diaz, Y; Moreno, S; Aceiton, J; Bruguera, A; Gutierrez-Macia, M; Imaz, A; Suanzes, P; Navarro, G; Orti, A; Miro, JM; Casabona, J; Reyes-Uruena, J
Tipo de documento: Artículo
Estado:Published version
Fecha de publicación:2022
País:España
Institución:Institut d'Investigació i Innovació Parc Taulí (I3PT)
Repositorio:r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
OAI Identifier:oai:i3pt.fundanetsuite.com:p1270
Acceso en línea:https://i3pt.portalinvestigacion.com/publicaciones/1270
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85137344633&doi=10.3390%2fmicroorganisms10081666&partnerID=40&md5=efb2cdee7678d0d31e8217c59e6528bf
Nivel de acceso:Acceso abierto
Palabra clave:HIV
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
coronavirus disease 2019 (COVID-19)
vaccination
vaccine effectiveness
_version_ 1878731751715504128
author Nomah, DK
author2 Llibre, JM
Diaz, Y
Moreno, S
Aceiton, J
Bruguera, A
Gutierrez-Macia, M
Imaz, A
Suanzes, P
Navarro, G
Orti, A
Miro, JM
Casabona, J
Reyes-Uruena, J
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author_browse Aceiton, J
Bruguera, A
Casabona, J
Diaz, Y
Gutierrez-Macia, M
Imaz, A
Llibre, JM
Miro, JM
Moreno, S
Navarro, G
Nomah, DK
Orti, A
Reyes-Uruena, J
Suanzes, P
author_facet Nomah, DK
Llibre, JM
Diaz, Y
Moreno, S
Aceiton, J
Bruguera, A
Gutierrez-Macia, M
Imaz, A
Suanzes, P
Navarro, G
Orti, A
Miro, JM
Casabona, J
Reyes-Uruena, J
author_role author
collection r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
description People living with HIV (PLWH) are prioritised for SARS-CoV-2 vaccination due to their vulnerability to severe COVID-19. Therefore, the epidemiological surveillance of vaccination coverage and the timely identification of suboptimally vaccinated PLWH is vital. We assessed SARS-CoV-2 vaccination coverage and factors associated with under-vaccination among PLWH in Catalonia, Spain. As of 11.12.2021, 9945/14942 PLWH (66.6%) had received >= 1 dose of a SARS-CoV-2 vaccine. Non-Spanish origin (adjusted odds ratio (aOR) 0.64, 95% CI 0.59-0.70), CD4 count of 200-349 cells/mu L (aOR 0.74, 95% CI 0.64-0.86) or 350-499 cells/mu L (aOR 0.79, 95% CI 0.70-0.88), detectable plasma HIV-RNA (aOR 0.61 95% CI 0.53-0.70), and previous SARS-CoV-2 diagnosis (aOR 0.58 95% CI 0.51-0.65) were associated with under-vaccination. SARS-CoV-2 diagnosis (437 [9.5%] vs. 323 [3.5%], p < 0.001), associated hospitalisations (10 [2.3%] vs. 0 [0%], p < 0.001), intensive care unit admissions (6 [1.4%] vs. 0 [0%], p < 0.001), and deaths (10 [2.3%] vs. 0 [0%], p < 0.001) were higher among unvaccinated PLWH. Vaccination coverage was lower among PLWH with a CD4 count >200 cells/mu L, detectable plasma HIV-RNA, previous SARS-CoV-2 diagnosis, and migrants. SARS-CoV-2 diagnosis, associated hospitalisations, and deaths among PLWH were lower among the vaccinated compared with the unvaccinated. SARS-CoV-2 vaccination prioritisation has not completely reached vulnerable PLWH with poorer prognosis. This information can be used to inform public health strategies.
eu_rights_str_mv openAccess
format article
id ES_35ca4100370bc706207a9a96f986f472
institution Institut d'Investigació i Innovació Parc Taulí (I3PT)
instname_str Institut d'Investigació i Innovació Parc Taulí (I3PT)
network_acronym_str ES
network_name_str España
oai_identifier_str oai:i3pt.fundanetsuite.com:p1270
publishDate 2022
publishDateSort 2022
publisher MDPI
publisherStr MDPI
reponame_str r-I3PT. Repositorio Institucional Producción Científica del Institut d'Investigació i Innovació Parc Taulí
spelling SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV Nomah, DK Llibre, JM Diaz, Y Moreno, S Aceiton, J Bruguera, A Gutierrez-Macia, M Imaz, A Suanzes, P Navarro, G Orti, A Miro, JM Casabona, J Reyes-Uruena, J HIV severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coronavirus disease 2019 (COVID-19) vaccination vaccine effectiveness People living with HIV (PLWH) are prioritised for SARS-CoV-2 vaccination due to their vulnerability to severe COVID-19. Therefore, the epidemiological surveillance of vaccination coverage and the timely identification of suboptimally vaccinated PLWH is vital. We assessed SARS-CoV-2 vaccination coverage and factors associated with under-vaccination among PLWH in Catalonia, Spain. As of 11.12.2021, 9945/14942 PLWH (66.6%) had received >= 1 dose of a SARS-CoV-2 vaccine. Non-Spanish origin (adjusted odds ratio (aOR) 0.64, 95% CI 0.59-0.70), CD4 count of 200-349 cells/mu L (aOR 0.74, 95% CI 0.64-0.86) or 350-499 cells/mu L (aOR 0.79, 95% CI 0.70-0.88), detectable plasma HIV-RNA (aOR 0.61 95% CI 0.53-0.70), and previous SARS-CoV-2 diagnosis (aOR 0.58 95% CI 0.51-0.65) were associated with under-vaccination. SARS-CoV-2 diagnosis (437 [9.5%] vs. 323 [3.5%], p < 0.001), associated hospitalisations (10 [2.3%] vs. 0 [0%], p < 0.001), intensive care unit admissions (6 [1.4%] vs. 0 [0%], p < 0.001), and deaths (10 [2.3%] vs. 0 [0%], p < 0.001) were higher among unvaccinated PLWH. Vaccination coverage was lower among PLWH with a CD4 count >200 cells/mu L, detectable plasma HIV-RNA, previous SARS-CoV-2 diagnosis, and migrants. SARS-CoV-2 diagnosis, associated hospitalisations, and deaths among PLWH were lower among the vaccinated compared with the unvaccinated. SARS-CoV-2 vaccination prioritisation has not completely reached vulnerable PLWH with poorer prognosis. This information can be used to inform public health strategies. MDPI https://i3pt.portalinvestigacion.com/publicaciones/1270 https://www.scopus.com/inward/record.uri?eid=2-s2.0-85137344633&doi=10.3390%2fmicroorganisms10081666&partnerID=40&md5=efb2cdee7678d0d31e8217c59e6528bf
spellingShingle SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV
Nomah, DK
HIV
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
coronavirus disease 2019 (COVID-19)
vaccination
vaccine effectiveness
status_str publishedVersion
title SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV
title_full SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV
title_fullStr SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV
title_full_unstemmed SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV
title_short SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV
title_sort SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV
topic HIV
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
coronavirus disease 2019 (COVID-19)
vaccination
vaccine effectiveness
topic_facet HIV
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
coronavirus disease 2019 (COVID-19)
vaccination
vaccine effectiveness
url https://i3pt.portalinvestigacion.com/publicaciones/1270
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85137344633&doi=10.3390%2fmicroorganisms10081666&partnerID=40&md5=efb2cdee7678d0d31e8217c59e6528bf